Head and Neck Cancer Registry (LORHAN)

Overview

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Full Title of Study: “Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2011

Interventions

  • Other: Therapy for head and neck cancer
    • radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy

Arms, Groups and Cohorts

  • Patients with head and neck cancer

Clinical Trial Outcome Measures

Primary Measures

  • Patterns of care for head and neck cancer
    • Time Frame: up to 10 years

Secondary Measures

  • Overall survival by treatment regimen
    • Time Frame: study entry to death from any cause or to end of study
  • Determine the incidence and severity of major dose-limiting and other important treatment toxicities
    • Time Frame: up to 10 years
  • Identify supportive care received for managing nutrition, pain, nausea and other complications
    • Time Frame: up to 10 years
  • tumor control by treatment regimen
    • Time Frame: study entry to progressive disease

Participating in This Clinical Trial

Inclusion Criteria

  • Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin – Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy – Written informed consent Exclusion Criteria:

  • Registry participation does not exclude participation in clinical trials. – Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Eli Lilly and Company
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Mednet Solutions, Study Director, MedNet Solutions

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.